TY - JOUR
AU - Ratcliff, Jeremy
AU - Nguyen, Dung
AU - Fish, Matthew
AU - Rynne, Jennifer
AU - Jennings, Aislinn
AU - Williams, Sarah
AU - Al-Beidh, Farah
AU - Bonsall, David
AU - Evans, Amy
AU - Golubchik, Tanya
AU - Gordon, Anthony C.
AU - Lamikanra, Abigail A.
AU - Tsang, Pat
AU - Ciccone, Nick A.
AU - Leuschner, Ullrich
AU - Laing, Emma
AU - Slack, Wendy
AU - Mouncey, Paul R.
AU - Ziyenge, Sheba
AU - Oliveira, Marta S.
AU - Ploeg, Rutger J.
AU - Rowan, Kathryn M.
AU - Shankar-Hari, Manu
AU - Roberts, David J.
AU - Menon, David K.
AU - Estcourt, Lise J.
AU - Simmonds, Peter
AU - Harvala, Heli
AU - REMAP-CAP Immunoglobulin Domain UK Investigators
PY - 2021
DA - May
TI - Virological Characterization of Critically Ill Patients With COVID-19 in the United Kingdom: Interactions of Viral Load, Antibody Status, and B.1.1.7 Infection
JO - The Journal of Infectious Diseases
EP - 605
VL - 224
IS - 4
DO - https://doi.org/10.1093/infdis/jiab283
AB - BACKGROUND: Convalescent plasma containing neutralizing antibody to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is under investigation for coronavirus disease 2019 (COVID-19) treatment. We report diverse virological characteristics of UK intensive care patients enrolled in the Immunoglobulin Domain of the REMAP-CAP randomized controlled trial that potentially influence treatment outcomes.
PB - Oxford University Press
UR - https://www.research.ed.ac.uk/en/publications/ccd272cc-f618-45a8-9649-3a16e8fe3d4f
KW - Coronavirus (COVID-19)
ER